CRISPR Therapeutics
CRSP
$53.74
Share price
-0.59%
Change (1 day)
-16.71%
Change (1 year)
CRISPR Therapeutics (CRSP) - P/B ratio
P/B ratio as of June 2024 : 2.20
According to CRISPR Therapeutics's latest financial reports the company has a price-to-book ratio of 2.20.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
CRISPR Therapeutics - P/B ratio (from 2016 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 2.64 | 55.63% |
| 2022-12-31 | 1.70 | -29.79% |
| 2021-12-31 | 2.42 | -63.11% |
| 2020-12-31 | 6.55 | 66.24% |
| 2019-12-31 | 3.94 | 4.33% |
| 2018-12-31 | 3.78 | -24.93% |
| 2017-12-31 | 5.03 | 45.27% |
| 2016-12-31 | 3.46 | |
| 2015-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 1.83 | -16.84% | 🇺🇸 USA |